NW

Nam W. Kim

Co-Founder, CEO & CTO

KDx Diagnostics

Therapeutic Areas

KDx Diagnostics Pipeline

DrugIndicationPhase
URO17® Bladder Cancer TestBladder Cancer Detection and MonitoringPivotal Clinical Trial